KATE POWERS: Open Payments
NPI 1346834868 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 9 payments from 6 companies in 2025. Trend: 2023 $619 · 2024 $295 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $156 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| GENZYME CORPORATION | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| Galderma Laboratories, L.P. | 1 | $20 |
| Organon LLC | 3 | $12 |
Products named: TREMFYA, DUPIXENT, RINVOQ, NEMLUVIO, VTAMA.
Industry payments across NJ — which companies pay providers there.
